Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.

Editor-in-Chief 
William C. Faquin, MD, PhD*
Massachusetts General Hospital
Boston, Massachusetts
Staff 
Esmeralda Galán Buchanan,
Senior Director, Journals and Books Publishing
Daniel Nadolny,
Managing Editor
Jasmine Coole,
Senior Editorial Assistant
Associate Editors 
Jeffrey Krane, MD, PhD
Clinician's Corner Editor
Massachusetts General Hospital
Boston, Massachusetts
Sinchita Roy-Chowdhuri, MD, PhD
Molecular Minute
MD Anderson Cancer Center
Houston, Texas
Esther Diana Rossi, MD, PhD, MIAC*
International Perspectives in Cytology
Catholic University of the Sacred Heart
Rome, Italy

Social Media and Informatics Editors 
Sara Jiang, MD
Emilio Madrigal, DO
Editorial Advisory Board 
Diane D. Davey, MD
Bridging the Gap Editor

Manon Auger, MD, FRCP(C)*
Andrew Field, MBBS, FRCPA, FIAC*
Vickie Jo, MD
Adele Kraft, MD*
Yael K. Heher, MD, MPH*
QA Q&A Editor

Sara Elizabeth Monaco, MD
Ritu Nayar, MD*
Michiya Nishino, MD, PhD
Mauro Saieg, MD, PhD*
David B. Kaminsky, MD, FIAC*
CytoSource Editor

Momin Siddiqui, MD, FIAC*
Gary Tse, MBBS, FRCPC, FCAP, MIAC
Christopher J. VandenBussche, MD, PhD*
David C. Wilbur, MD
Dr. Davey is a minor stock shareholder of Johnson & Johnson and Express Scripts. She has no other financial relationships to disclose.
Dr. VandenBussche serves as a consultant on processing and adequacy of pathology specimens for Personal Genome Diagnostics. He has no other financial relationships or interests to disclose.
Dr. Wilbur serves as a compensated consultant for Corista, and for Visiongate (for which he has received stock options.) He has no other financial relationships or interests to disclose.
*No financial relationships or interests to disclose.
EDITORIAL REVIEW BOARD
Zubair W. Baloch, MD, PhD
Guliz Barkan, MD, FIAC,FABP
Christine Bergeron, MD, PhD
George Birdsong, MD
Massimo Bongiovanni, MD
Lukas Bubendorf, MD
Guoping Cai, MD
Joan Cangiarella, MD
Ivan A. Chebib, MD
Lan Chen
Longwen Chen, MD
Mark Chien-Chin Chen, MD, MSc, FIAC
Ed Cibas, MD
Amy Clayton, MD
Beatrix Cochand-Priollet, MD, MIAC, PhD
William Crabtree, PhD
Gilda da Cunha Santos, MD, PhD, FRCPC, FIAC
Armando C. Filie, MD
Christopher Griffith, MD, PhD
Michael Idowu, MD, MPH
Chris Jensen, MD
Kusum Kapila, MBBS, MD, FRCPath, FIAC
Jerzy Klijanienko, MD, PhD, MIAC
Savitri Krishnamurthy, MD
Oscar Lin, MD, PhD
Xiaoqi Lin, MD, PhD
Britt-Marie E. Ljung, MD
Alarice Lowe, MD
Zahra Maleki, MD
Sharon Mount, MD
Christopher N. Otis, MD
Liron Pantanowitz, MD
Martha Pitman, MD
Marc Pusztaszeri, MD
Xiaohua Qian, MD, PhD
Andrew Renshaw, MD
Jordan Reynolds, MD
Dorothy L. Rosenthal, MD, FIAC
Beatriz A. Salvagno, MD, PhD
Fernando Schmitt, MD, PhD
Mary Schwartz, MD
Mary K. Sidawy, MD
Rosemary Tambouret, MD
Giancarlo Troncone, MD, PhD
Louis J. Vaickus, MD, PhD
Paul VanderLaan, MD, PhD
Philippe Vielh, MD, PhD, FIAC
Vivian Weiss, MD, PhD
Austin Wiles, MD
Jack Yang, MD
Maureen F. Zakowski, MD
Editor Emerita 
Celeste N. Powers, MD, PhD